Marc Bonneville

Marc Bonneville

Auto-generated profile, based on publicly available information

Marc Bonneville

Institut Mérieux, Lyon, France

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 1999 in International Immunology
Verified
Journal Article
Open access
PDF file
JTJean-Luc Taupin
Jean-Luc Taupin
FHFranck Halary
Franck Halary
JDJulie Déchanet
Julie Déchanet
MPMarie-Alix Peyrat
Marie-Alix Peyrat
JRJean-Marie Ragnaud
Jean-Marie Ragnaud
JMJean-Francıois Moreau
Jean-Francıois Moreau
Although T cell clone monospecificity is ensured by several allelic exclusion processes operating at either the genotypic or phenotypic levels, clones expressing two distinct αβ or γδ TCR have been described in several instances. Thus far, the origin of dual TCR-expressing cells and the homeostatic mechanisms controlling the size of this subset in the periphery remain poorly understood. In the course of a phenotypic analysis of γδ T cells in HIV-infected patients, we detected the presence of a T cell subset stained by both Vδ2- and Vδ3-specific mAb, which represented a large fraction (up to 16.5%) of γδ peripheral blood lymphocytes (PBL) in one HIV patient. The presence of two distinct functional δ chains on these cells was confirmed by phenotypic and molecular analysis of TCR transcripts expressed by Vδ2+Vδ3+ T cell clones derived from this patient. For 18 months, the absolute number of these cells varied similarly to the other PBL subsets, before becoming undetectable in blood samples. Moreover, most of these cells expressed CD8 receptors, which are classically found on activated, but not resting, γδ T cells. Taken together, these data suggest that dual TCR-expressing T cells are subjected to peripheral expansions and contractions presumably following antigen recognition, which would argue against a systematic counter-selection of these cells during peripheral antigen-driven responses.

1 December 1992 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
HVH Vié
H Vié
TGThierry Gauthier
Thierry Gauthier
RBR Breathnach
R Breathnach
MBM Bonneville
M Bonneville
AGA Godard
A Godard
YJY Jacques
Y Jacques
We have constructed a hybrid cDNA coding for a fusion protein between human interleukin 2 and a truncated heavy chain from human immunoglobulin M. The protein encoded by this cDNA contains the entire interleukin 2 sequence including its signal peptide, fused at its C terminus to domains 2 to 4 of the immunoglobulin heavy-chain constant region. Cells transfected with the hybrid cDNA secrete multimeric forms of the fusion protein, which bind specifically to cells bearing high-affinity interleukin 2 receptors. This binding leads either to T-cell proliferation or, if complement is added, to T-cell death. Multimeric forms of the fusion protein with a molecular mass above 500 kDa mediate complement-dependent lysis but trigger proliferation inefficiently when compared with forms with a low molecular mass (< 500 kDa). In contrast, the latter efficiently mediate T-cell proliferation without inducing complement-dependent lysis. The high molecular mass fusion proteins could thus constitute valuable tools for specific immunosuppression in humans.

1 January 1996 in Journal of Immunological Methods
Verified
Journal Article
Closed access
FRFrançois Romagné
François Romagné
MPMarie Alix Peyrat
Marie Alix Peyrat
CLCorinne Leget
Corinne Leget
FDFrançois Davodeau
François Davodeau
IHIsabelle Houde
Isabelle Houde
MBMarc Bonneville
Marc Bonneville

1 July 1995 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JGJoëlle Gaschet
Joëlle Gaschet
NMN. Milpied
N. Milpied
CDC. Denis
C. Denis
MHM. M. Hallet
M. M. Hallet
FDF. Davodeau
F. Davodeau
HVH. Vié
H. Vié

1 November 1998 in Research in Immunology
Verified
Journal Article
Closed access
LALuciano Adorini
Luciano Adorini
MBM. Bonneville
M. Bonneville
GKG. Kollias
G. Kollias

4 January 2025 in Open Access Government
Verified
Journal Article
Open access
JMJennifer B.H Martiny
Jennifer B.H Martiny
ECEstelle Couradeau
Estelle Couradeau
FFFanette Fontaine
Fanette Fontaine
CBChristian Brechot
Christian Brechot
MBMarc Bonneville
Marc Bonneville
KCKarel Callens
Karel Callens
Microbiomes should be incorporated into The One Health Joint Plan of Action: The One Health Joint Plan of Action was created by major international organizations to tackle global health issues related to human, animal, plant, and environmental health. This article emphasizes the importance of integrating microbiomes into this framework to enhance health systems and prevention strategies. In 2022, four major international organizations—the Food and Agriculture Organization of the United Nations (FAO), the United Nations Environment Programme (UNEP), the World Health Organization (WHO), and the World Organisation for Animal Health (WOAH)—introduced the One Health Joint Plan of Action (2022-2026). This initiative outlines an ambitious framework to address global health challenges at the intersection of human, animal, plant, and environmental health. In particular, the document recognizes that individual disease-causing microorganisms and those that carry antimicrobial resistance (AMR) interact at this intersection. Yet despite its comprehensive scope, the plan omits explicit mention of microbiomes. This omission undervalues the potential for microbiome-based solutions to address global health challenges and misses an opportunity to move towards more proactive prevention through microbiome-based approaches.